Circulation, Vol 85, 1286-1292, Copyright © 1992 by American Heart Association
N Colyvas, JH Rapp, NR Phillips, R Stoney, S Perez, JP Kane and RJ Havel
BACKGROUND. To examine the relation of plasma lipoproteins to the
proliferative response after arterial injury in humans, we examined the
plasma lipid, lipoprotein, and apoprotein levels of 20 patients with early
recurrent stenosis caused by intimal hyperplasia after carotid
endarterectomy. These were compared with 20 controls who had no evidence of
recurrent stenosis by duplex ultrasound scanning. METHODS AND RESULTS. By
univariate analysis, the reoperated patients had higher levels of plasma
cholesterol (251 versus 225 mg/dl, p less than 0.05), total triglycerides
(173 versus 105 mg/dl, p less than 0.03), and low density lipoprotein (LDL)
apoprotein B (99.8 versus 77.2 mg/dl, p less than 0.003). The ratio of
cholesterol to apoprotein B in LDL was lower in patients with restenosis (p
less than 0.04), suggesting LDL of smaller diameter. High density
lipoprotein (HDL) cholesterol level was reduced (45 versus 55 mg/dl, p less
than 0.01) in patients with restenosis. With statistical adjustment for the
correlations between these variables by multivariate analysis, both LDL
apoprotein B and HDL cholesterol were independent predictors of the risk of
restenosis. Ten patients with restenosis but only two controls had one or
two apolipoprotein E4 alleles. CONCLUSIONS. Elevated lipid levels usually
associated with an increased risk of atherosclerosis may predispose
patients to an increased incidence of intimal hyperplasia after
endarterectomy.
ARTICLES
Relation of plasma lipid and apoprotein levels to progressive intimal hyperplasia after arterial endarterectomy
Cardiovascular Research Institute, University of California, San Francisco.
This article has been cited by other articles:
![]() |
R. H. Samson The Role of Statin Drugs in the Management of the Peripheral Vascular Patient Vascular and Endovascular Surgery, August 1, 2008; 42(4): 352 - 366. [Abstract] [PDF] |
||||
![]() |
C. D. Liapis and K. I. Paraskevas Factors Affecting Recurrent Carotid Stenosis Vascular and Endovascular Surgery, January 1, 2005; 39(1): 83 - 95. [Abstract] [PDF] |
||||
![]() |
C. Parolini, G. Chiesa, Y. Zhu, T. Forte, S. Caligari, E. Gianazza, M. G. Sacco, C. R. Sirtori, and E. M. Rubin Targeted Replacement of Mouse Apolipoprotein A-I with Human ApoA-I or the Mutant ApoA-IMilano. EVIDENCE OF APOA-IM IMPAIRED HEPATIC SECRETION J. Biol. Chem., February 7, 2003; 278(7): 4740 - 4746. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I Circulation, November 6, 2001; 104(19): 2376 - 2383. [Full Text] [PDF] |
||||
![]() |
L. Ferrucci, J. M. Guralnik, M. Pahor, T. Harris, M.-C. Corti, M.-C. MHS, B. T. Hyman, R. B. Wallace, and R. J. Havlik Apolipoprotein E {epsilon}2 Allele and Risk of Stroke in the Older Population Stroke, December 1, 1997; 28(12): 2410 - 2416. [Abstract] [Full Text] |
||||
![]() |
M. R. Soma, E. Donetti, C. Parolini, C. R. Sirtori, R. Fumagalli, and G. Franceschini Recombinant Apolipoprotein A-IMilano Dimer Inhibits Carotid Intimal Thickening Induced by Perivascular Manipulation in Rabbits Circ. Res., March 1, 1995; 76(3): 405 - 411. [Abstract] [Full Text] |
||||
![]() |
J. Stinson, G. D'Arcy, T. Cooke, M. P. Colgan, M. Hall, J. Tyrrell, K. Gaffney, M. Grouden, D. Moore, D. G. Shanik, et al. Elevated Lipoprotein (a) in Carotid Artery Atherosclerosis is Unrelated to Restenosis After Endarterectomy Vascular and Endovascular Surgery, January 1, 1995; 29(1): 23 - 27. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |